Talk about a heavy lift. A 22-year-old Brazilian woman has a new lease on life after surgeons removed 22 pounds of excess ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

A new study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) at the ...